Sensars

🚀 We’re honored to be featured in VentureBeat! 🚀 At Sensars, we are on a mission to revolutionize diabetic neuropathy care. Our innovative intra-nerve technology, SENSY, restores natural sensations to prevent life-altering complications like ulcers, falls, and amputations and treat pain. 🔗 Check out the full article here: https://lnkd.in/gVKrjh4q Thanks Jon Stojan for the article. Millions of people with diabetic neuropathy deserve better outcomes — and we’re committed to delivering them. 🌟 #Innovation #HealthTech #DiabeticNeuropathy #MedTech #VentureBeat

🚀 Big News Alert! 🚀 We're thrilled to announce that we've been named one of Hello Tomorrow’s Deep Tech Pioneers! 🌍✨ Join us at the 10th Hello Tomorrow Global Summit on March 13-14, 2025, and connect with the world’s top innovators, industry leaders, investors, and deep tech visionaries. This summit is where groundbreaking ideas meet powerful networks—let's shape the future of deep tech together! Don’t miss out! 👉https://lnkd.in/g8keznYm #DeepTech #Innovation #HelloTomorrow #Sensars #Neurotechnology #TechForGood #FutureOfHealthcare #DiabeticNeuropathy #DeepTechPioneers #GlobalSummit Francesco Maria Petrini Guy Siman Silvestro Micera Michele G. Venture Kick Health Wildcatters

🌍 Today is World Diabetes Day – raising awareness of diabetes and its severe complications. At Sensars, we’re focused on one of the toughest challenges: diabetic neuropathy. This condition leads to sensory loss, making simple actions—walking, balancing, feeling touch, sleeping—extremely difficult. 🧠 Our SENSY technology is restoring what diabetic neuropathy takes away: natural foot sensation. We aim to prevent life-altering complications like falls, ulcers, amputations, and pain, helping people reclaim their independence and mobility. Let’s #EndDiabetesComplications together. Sensars is committed to innovative solutions that go beyond symptom relief to truly improve lives. #WorldDiabetesDay #DiabetesAwareness #DiabeticNeuropathy #HealthcareInnovation #Sensars Guy Siman Francesco Maria Petrini

🌟 Transforming Diabetic Neuropathy Care 🌟 We’re thrilled to share an article by Venture Capital Post that highlights Sensars’ pioneering intraneural technology. Our solution, initially developed at EPFL in Silvestro Micera's lab, and further advanced under CEO Francesco Maria Petrini and COO Guy Siman lead, is the only implantable device that restores natural foot sensation, tackling diabetic neuropathy complications like ulcers, amputations, falls and pain. We’re committed to reclaiming quality of life for millions affected by this condition. #DiabeticNeuropathy #DiabeticFootCare #Neuromodulation https://lnkd.in/eXihiFhs

Next week our CEO Francesco Maria Petrini and COO Guy Siman will showcase Sensars for the Health Wildcatters 2024 Pitch Day on 11/14. If you are around Dallas, come watch us and the other great startups of 2024 cohort. Subscribe here: https://lnkd.in/gXfpHBYP

Big news! Sensars was just featured in an article about our innovative approach to diabetic neuropathy care. We’re helping people prevent falls, ulcers, amputations, relieve pain, and get back on their feet. 🚶♂️ 🔗 Read the full article here: https://lnkd.in/ecdZyNQ2 Thank you Grit Daily News Spencer Hulse for the feature! 🙏 Francesco Maria Petrini Guy Siman Silvestro Micera Venture Kick Michele G. Marco Gullà Health Wildcatters #DiabeticNeuropathy #NeuropathyCare #AmputationPrevention #Neurotechnology #MedicalBreakthrough

🚀 Transforming Diabetic Neuropathy Treatment with AI & Neurostimulation 🚀 By directly engaging with peripheral nerves, our innovative solution offers renewed hope to millions struggling with this condition. With the ability to restore sensation to the feet, we can significantly reduce the risk of ulcers, amputations, and falls, while also providing effective pain relief. 💡 Enjoy this inteview of Sensars' COO Guy Siman! https://lnkd.in/dBPkzZBf #PainManagement #DiabeticNeuropathy #AIinHealthcare #Neurostimulation #HealthcareInnovation #PainManagement #DiabeticNeuropathy #FutureOfMedicine

🚀 Exciting News for Sensars! 🚀 We are thrilled to announce that Sensars has been selected out of 700 applications to join Health Wildcatters, a prestigious American accelerator program! 🎉 This two-month program marks our first step towards entering the U.S. market, a key milestone in our journey. 💡 What We Do at Sensars: We are on a mission to tackle diabetic neuropathy, a massive and often overlooked problem. In the U.S. alone, the direct costs due to diabetic neuropathy are $50 billion per year—equivalent to the costs of cardiovascular diseases. Our innovative solution restores natural sensory feedback, helping to prevent falls, ulcers, amputations, and even treat pain, which is a critical aspect for improving patient quality of life. 📈 Looking Ahead: We are launching a financing round to support our next steps. If you’re interested in learning more about our journey and investment opportunities, please reach out! Thank you to Health Wildcatters for this incredible opportunity, and to everyone who has supported us along the way. We’re just getting started! 💪 Francesco Maria Petrini Guy Siman Silvestro Micera #healthtech #diabeticneuropathy #innovation #USmarket #startup

Sensars is on the news again!!! Neurotech Reports highlights Sensars as an emerging company with groundbreaking technology for the treatment of painful diabetic neuropathy. Using our novel approach for neurostimulation, the intra-nerve electrode array, Sensars aims to not only significantly reduce pain, but also improve quality of life through the restoration of sensations to diabetic feet (potentially improving balance and reducing chances of foot ulcers). Stay tuned for more to come… Francesco Maria Petrini Guy Siman Thank you Jeremy Koff, James Cavuoto, JoJo Platt at Neurotech Reports #Neurostimulation #DiabeticNeuropathy #Innovation #Sensars #PainManagement https://lnkd.in/gddj4HRh

Sensars secured €1.1M to advance its neuromodulation technologies, including a €500,000 Eurostars grant for its SENSOLE project and a pre-seed investment from HTH. Additionally, Sensars Germany received €600,000 from BMBF to test the SENSY neurostimulator in amputees. These funds will support Sensars' efforts to improve treatments for chronic pain and sensory loss. Learn more: https://lnkd.in/e6uEnFGE #neurotech #neuromodulation #neuropathic #pain